CONFIDENTIAL SETTLEMENT AGREEMENT AND GENERAL RELEASEConfidential Settlement Agreement and General Release • August 8th, 2018 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This Settlement Agreement and General Release (the “Agreement”) is entered into this 18th day of April 2018 (the “Effective Date”) by and among Alnylam Pharmaceuticals, Inc., a Delaware corporation with a principal place of business at 300 Third Street, Cambridge, MA 02142 (“Alnylam”), and Dicerna Pharmaceuticals, Inc., a Delaware corporation with a principal place of business at 87 Cambridgepark Drive, Cambridge, MA 02140 (“Dicerna”). Each of Alnylam and Dicerna shall be considered a “Party,” and collectively they shall be considered the “Parties.”
SHARE ISSUANCE AGREEMENTShare Issuance Agreement • August 8th, 2018 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS SHARE ISSUANCE AGREEMENT (this “Agreement”), is made as of April 20, 2018, by and between Alnylam Pharmaceuticals, Inc., a Delaware corporation (the “Share Acquiror”), and Dicerna Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
